R.A. Session, Founder of Taysha Gene Therapies

R.A. Session is the founder of Taysha Gene Therapies. Taysha Gene Therapies has raised $30M in total funding. Latest round: Seed.

About R.A. Session

R.A. Session II is the President, CEO, and Founder of Taysha Gene Therapies, a biotech startup focused on developing therapies for severe and life-threatening monogenic central nervous system (CNS) diseases. The company launched with $30 million in seed financing and a strategic partnership with the UT Southwestern Gene Therapy Program. Taysha Gene Therapies was founded in 2019.

R.A. Session at a glance

More founders in Dallas, United States (44)

Browse related founder lists (4)

Full founder directory · Investor directory · Company funding database · Fundraising library